For this reason, the rapid zebrafish in vivo model appeared as a useful analytical tool to investigate the effects of dynamin-2 mutations on the neuromuscular system in CNM and CMT. This evidence concerns the gene DNM2 and Charcot-Marie-Tooth disease.